Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03771443
Other study ID # CEBD-CU-2018-12-01
Secondary ID
Status Completed
Phase Phase 3
First received
Last updated
Start date July 21, 2019
Est. completion date January 21, 2020

Study information

Verified date July 2020
Source Cairo University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Celiac disease (CD) is the most common genetically based food intolerance in the world, with a prevalence among approximately 1% of the general population (Guandalini & Assiri, 2014). CD is a frequent disorder among Egyptian children, both in the general population and in at-risk groups(Abu-Zekry et al., 2008). It is estimated that the incidence of CD is 3 to13 cases per1000, with a higher prevalence among first-degree relatives of patients with CD.Lifelong adherence to a strict gluten free diet (GFD) remains the only available treatment for patients with CD and typically results in a complete return to health. Nevertheless, gluten is not found only in diet, Gluten is commonly used as a binder in products like medication, cosmetics, oral and skin care, and even children's toys. Gluten is found also in toothpastes and other oral health products and it can be swallowed by mistake and initiate immune response(Anon, n.d.). Unfortunately, there is no gluten free toothpaste available in the Egyptian market and it is very expensive if we bought it from Europe or USA. The tube will cost nearly 10 dolars .As a result, the production and availability of gluten free toothpaste in Egypt has become mandatory.


Description:

production of an experimental gluten free toothpaste and providing it for children with celiac disease


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date January 21, 2020
Est. primary completion date January 21, 2020
Accepts healthy volunteers No
Gender All
Age group 6 Years to 15 Years
Eligibility Inclusion Criteria:

1. Age above 6 yeas.

2. Erupting lower 6.

3. Can spit the toothpaste.

4. Diagnosed as a celiac patient(pathology&serology)

Exclusion Criteria:

1. With a history of allergy to any ingredient present in the toothpaste to be used for treatment

2. The presence of serious medical conditions or a transmissible disease such as malignant disease, hepatitis, AIDS etc.

3. Children whose parents had no home or mobile phone to enable post-operative contact.

4. Parent that will not sign the consent.

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
experimental gluten free toothpaste
we prepared gluten free toothpaste in the faculty of pharmacy -Cairo university because there is no gluten free toothpaste available in the Egyptian market .

Locations

Country Name City State
Egypt Faculty of Dentistry, Cairo University Giza Al Manial, Cairo, Egypt

Sponsors (1)

Lead Sponsor Collaborator
Cairo University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary Ulcerative events Reporting from the parent (Yes or No) Six months
Secondary Inflammation or ulceration visual (Yes or No) six months
See also
  Status Clinical Trial Phase
Recruiting NCT05555446 - Bovine Colostrum to Prevent Absorption of Gluten Early Phase 1
Completed NCT03288831 - Changes in Intestinal Permeability 4 Hours After Gluten Challenge N/A
Completed NCT04247737 - Gluten Free Diet in IBS N/A
Active, not recruiting NCT03678935 - Effect of FODMAP Restriction on Persistent GI-symptoms in Coeliac Patients N/A
Completed NCT03543540 - Bioequivalence Study of Nexvax2 in Subjects With Celiac Disease Phase 1
Completed NCT01485341 - Gluten Sensitivity in Non-Celiac Patients Phase 3
Completed NCT01558557 - Gluten Free Diet in People With Schizophrenia: A Pilot Study N/A
Recruiting NCT05803408 - RCT: Effect of Late vs Early Introduction of Gluten-free Oats on Patients With Newly Diagnosed Celiac Disease. N/A
Recruiting NCT03183609 - Confirmatory Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons With Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies (AGA IG) N/A
Completed NCT03020511 - Effects of Ancient Grains-based Diet in a Closed Community N/A
Recruiting NCT05209568 - Immune Responses to Gluten N/A
Recruiting NCT05644782 - Dietary Approach to Mild-to-moderate Psoriasis N/A
Completed NCT03638544 - Reduced Content of Gluten Diet on Patients With Irritable Bowel Syndrome (Pro.Ali.Fun.) N/A
Recruiting NCT03089632 - The Effect of Gluten-free Diet in Type 1 Diabetics With Dyspepsia Symptoms N/A
Active, not recruiting NCT03644069 - A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD) Phase 2
Recruiting NCT02431585 - Prevalence of Gluten Sensitivity in Irritable Bowel Syndrome: The First Study in Paediatrics. N/A
Completed NCT03268720 - Influence of the Immunosystem in Non-celiac Glutensensitivity N/A
Suspended NCT03462979 - Effects of Home Gluten Immunogenic Peptide Testing on Children With Celiac Disease N/A
Not yet recruiting NCT03329534 - Gluten Related Disorders in Barrett's Esophagus N/A